Evogene Reports Positive Phase 1 Data for BMC128 in Cancer
REHOVOT, Israel, June 2, 2026 Evogene Ltd. has announced the successful completion of the first-in-human Phase 1 clinical study...
acquisition
Advertisement
Resmed Completes Noctrix Health Acquisition to Expand Sleep Care
SAN DIEGO, June 1, 2026 Resmed has completed its acquisition of Noctrix Health, significantly expanding its clinical sleep health...
Nona Biosciences Appoints Josh Xiao as New CSO
CAMBRIDGE, Mass., May 6, 2026 Nona Biosciences, a global biotechnology company specializing in biotherapeutic discovery and AI-driven drug development...
Bayer to Acquire Perfuse Therapeutics in $2.45B Deal
BERLIN, Germany, and SAN FRANCISCO, Calif., May 6, 2026 Bayer has announced an agreement to fully acquire Perfuse Therapeutics...
UCB to Acquire Candid Therapeutics in $2.2B Immunology Deal
SAN DIEGO, CALIFORNIA, May 03, 2026 UCB has announced a definitive agreement to acquire Candid Therapeutics in a transaction...
Advertisements
SK Capital Partners Sells Noramco Group to Siegfried
NEW YORK, NY, May 1, 2026 SK Capital Partners, LP announced the successful completion of the sale of Noramco...
Amneal Accelerates Growth with Kashiv BioSciences Deal
Bridgewater, New Jersey, USA – April 22, 2026 In a transformative move within the global biopharmaceutical landscape, Amneal Pharmaceuticals...
Gilead Secures Approvals for Arcellx Acquisition Deal
FOSTER CITY, Calif., April 17, 2026 Gilead Sciences, Inc. has announced that it has obtained all required regulatory approvals...
Eli Lilly to Acquire CrossBridge Bio for ADC Platform
Houston, Texas, U.S. | April 15, 2026 Eli Lilly and Company has announced a strategic agreement to acquire CrossBridge...
Samsung Biologics Acquires GSK U.S. Manufacturing Site
INCHEON, South Korea & ROCKVILLE, Maryland, USA — March 31, 2026 Samsung Biologics has officially completed the acquisition of...
Advertisement
